MedTrace Logo

Ketamine Continuous Infusion on Opioid Consumption and Pain Management in Severe Burned Patients

NCT02860117 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2021-05-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of ketamine in continuous infusion in the control of pain intensity, the impact on the consumption of opioids and observe the side effect profile in patients suffering from great extent of burns.

Conditions

  • Pain, Burning

Interventions

DEVICE

Ketamine continuous infusion

Ketamine 0.1% 250mL continuous infusion (0,2ml/kg/h)

DRUG

Placebo

Placebo continuous infusion (0,2 ml/kg/h)

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Claudia Palmeira, MD, PhD · University of Sao Paulo General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2019-01-01
Completion
2020-05-01

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02860117 on ClinicalTrials.gov